Jeff Davis, a partner in the Washington, D.C., law office of Bass, Berry & Sims, advises healthcare organizations on Medicare and Medicaid billing and reimbursement issues, with a special focus on the ...

AHA president has asked Congress to intervene and demand HHS take a position on “drug companies’ attempts to hijack the 340B ...

On February 17, 2026, the Health Resources and Services Administration (HRSA) published a Request for Information (RFI) in the Federal Register seeking input on the potential implementation of a ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...

On July 31, the US Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) announced the availability of a new pilot program altering how pharmaceutical ...

The 340B Rebate Model Pilot Program, unveiled this summer, consists of a selected group of drugs of manufacturers that have submitted plans meeting specific criteria approved by the Health Resources ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Providers are urging the government to abandon any plans to implement after-the-fact rebates in the 340B drug discount program, arguing it would impose undue costs on hospitals and clinics and ...

The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling ...